Pitavastatin

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1278 publications

Safety concerns associated with various types of statins: a disproportionality analysis of the FAERS database.

Safety concerns associated with various types of statins: a disproportionality analysis of the FAERS database.

Journal: Expert opinion on drug safety
Published: April 03, 2026

Atorvastatin suppresses HIV/antiretroviral drug-induced cardiac fibrosis and dysfunction in mice by blocking platelet TGFβ1 signaling.

Atorvastatin suppresses HIV/antiretroviral drug-induced cardiac fibrosis and dysfunction in mice by blocking platelet TGFβ1 signaling.

Journal: JCI insight
Published: March 03, 2026

Targeting HIF-2α in Colorectal Cancer Reveals a Cholesterol Biosynthesis-Dependent Ferroptotic Vulnerability.

Targeting HIF-2α in Colorectal Cancer Reveals a Cholesterol Biosynthesis-Dependent Ferroptotic Vulnerability.

Journal: bioRxiv : the preprint server for biology
Published: February 12, 2026

A Two Birds with One Stone Strategy: Sialic Acid-Modified Pitavastatin Liposomes for Combating Atherosclerosis and Tumors.

A Two Birds with One Stone Strategy: Sialic Acid-Modified Pitavastatin Liposomes for Combating Atherosclerosis and Tumors.

Journal: Molecular pharmaceutics
Published: February 06, 2026

Economic implications of the different statin prescribing patterns in Central Portugal: a longitudinal analysis.

Economic implications of the different statin prescribing patterns in Central Portugal: a longitudinal analysis.

Journal: Journal of pharmaceutical policy and practice
Published: January 23, 2026

Redox-responsive drug delivery nanoparticles with integrated capabilities of ROS scavenging, lipid removal and anti-inflammation.

Redox-responsive drug delivery nanoparticles with integrated capabilities of ROS scavenging, lipid removal and anti-inflammation.

Journal: Biomaterials advances
Published: January 18, 2026

Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVE.

Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVE.

Journal: Journal of the American Heart Association
Published: December 11, 2025

Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphate.

Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphate.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Clonal Hematopoiesis and Major Adverse Cardiac Events in People With HIV: Insights From the REPRIEVE Trial.

Clonal Hematopoiesis and Major Adverse Cardiac Events in People With HIV: Insights From the REPRIEVE Trial.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 06, 2025

A Case of Statin-Associated Muscle Symptoms (SAMS) Due to Drug-Drug Interaction between Statin and Pazopanib

A Case of Statin-Associated Muscle Symptoms (SAMS) Due to Drug-Drug Interaction between Statin and Pazopanib

Journal: Hinyokika kiyo. Acta urologica Japonica
Published: November 06, 2025

Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis.

Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis.

Journal: The lancet. HIV
Published: October 31, 2025

Three-drug combination therapy to prevent glucocorticoid-associated osteonecrosis in patients with systemic lupus erythematosus: a proof-of-concept study.

Three-drug combination therapy to prevent glucocorticoid-associated osteonecrosis in patients with systemic lupus erythematosus: a proof-of-concept study.

Journal: Therapeutic advances in musculoskeletal disease
Published: October 31, 2025
Showing 1-12 of 1,278

Last Updated: 04/28/2026